EMA approval process for anticancer agents: What should the oncologist know? - Annual Congress of European Society for Medical Oncology by NewsFarma

MSD

data

EMA approval process for anticancer agents: What should the oncologist know?

Chair(s): M. Strijbos, BE; R. Califano, GB

EMA approval process for anticancer agents: What should the oncologist know?

11:00 - 11:25

F. Pignatti, London, GB

Interactive discussion with audience

11:25 - 12:00

Informação Adicional

Data de Início: sábado, 08 outubro 2016
Data de Fim: sábado, 08 outubro 2016
Horário: 11:00 – 12:00
Localidade: Lisbon

Área Reservada

Pesquisa

Agenda

out07

14:00 - 15:30

Joint Symposium ESMO-WHO Europe: To screen or not to screen for breast cancer?

Berlin

out07

18:00 – 20:00

The Science and Application of Checkpoint Inhibitors Across Melanoma, Head and Neck, and Genitourinary Cancers: What Have We Learned and Next Steps?

Rome

out08

11:00 - 12:30

Genetics and epigenetics of gastric cancer: What clinicians should know

Stockholm

out08

11:00 – 12:00

EMA approval process for anticancer agents: What should the oncologist know?

Lisbon

Os portugueses no ESMO 2016

Dr. Hélder Mansinho

Dr. Miguel Abreu

Prof.ª Doutora Fátima Cardoso

Prof.ª Doutora Fátima Carneiro

Dr. Paulo Cortes

Dr.ª Ana Castro

Dr. Henrique Queiroga

Prof. Doutor António Araújo

Dr.ª Ana Barroso

Dr.ª Encarnação Teixeira

Prof. Doutor Carlos Caldas

Dr. César Martins

Dr. Nuno Couto

Dr.ª Cláudia Vieira

Dr.ª Joana Ribeiro

Dr.ª Mariana Inácio

Dr.ª Rita Sousa

Dr.ª Teresa Amaral

Dr.ª Ana Coelho

Dr.ª Sofia Braga

Prof. Doutor Ramon de Mello